HMSY has been the topic of a number of other reports. Zacks Investment Research cut shares of HMS from a “hold” rating to a “sell” rating in a research report on Wednesday, April 3rd. William Blair reiterated an “outperform” rating on shares of HMS in a research report on Thursday, March 14th. Finally, Cantor Fitzgerald reiterated a “hold” rating and set a $34.00 price target on shares of HMS in a research report on Friday, February 22nd. One equities research analyst has rated the stock with a sell rating, three have assigned a hold rating and ten have assigned a buy rating to the stock. The stock presently has an average rating of “Buy” and an average target price of $33.04.
NASDAQ HMSY traded up $1.11 on Friday, reaching $30.51. 468,400 shares of the company’s stock traded hands, compared to its average volume of 615,391. HMS has a 12 month low of $17.11 and a 12 month high of $38.15. The company has a debt-to-equity ratio of 0.34, a current ratio of 4.40 and a quick ratio of 4.40. The stock has a market capitalization of $2.52 billion, a P/E ratio of 36.32, a PEG ratio of 2.71 and a beta of 1.61.
In other news, Director Bart M. Schwartz sold 20,000 shares of the firm’s stock in a transaction that occurred on Wednesday, March 13th. The shares were sold at an average price of $32.41, for a total value of $648,200.00. Following the transaction, the director now owns 74,874 shares in the company, valued at $2,426,666.34. The sale was disclosed in a document filed with the Securities & Exchange Commission, which can be accessed through the SEC website. Also, insider Meredith W. Bjorck sold 2,362 shares of the firm’s stock in a transaction that occurred on Monday, April 15th. The stock was sold at an average price of $30.10, for a total transaction of $71,096.20. Following the completion of the transaction, the insider now owns 51,755 shares in the company, valued at approximately $1,557,825.50. The disclosure for this sale can be found here. Insiders sold 1,018,795 shares of company stock worth $35,023,853 in the last 90 days. Company insiders own 2.87% of the company’s stock.
Institutional investors have recently modified their holdings of the company. Oregon Public Employees Retirement Fund bought a new position in shares of HMS in the fourth quarter worth approximately $32,000. Financial Gravity Wealth Inc. bought a new position in shares of HMS in the first quarter worth approximately $46,000. We Are One Seven LLC bought a new position in shares of HMS in the fourth quarter worth approximately $84,000. LS Investment Advisors LLC grew its holdings in shares of HMS by 80.0% in the fourth quarter. LS Investment Advisors LLC now owns 5,016 shares of the business services provider’s stock worth $141,000 after purchasing an additional 2,230 shares during the last quarter. Finally, BlueMountain Capital Management LLC bought a new position in shares of HMS in the third quarter worth approximately $146,000. Hedge funds and other institutional investors own 93.48% of the company’s stock.
HMS Company Profile
HMS Holdings Corp., through its subsidiaries, provides cost containment solutions in the United States healthcare marketplace. The company offers coordination of benefits services to government and commercial healthcare payers to ensure that the correct party pays the claim; and population management solutions that provide risk-bearing organizations with intelligence across their member populations to identify risks, and enhance patient engagement and outcomes, as well as payment integrity, care management and consumer engagement, and analytical solutions.
Recommended Story: What impact do institutional investors have on markets?
Receive News & Ratings for HMS Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for HMS and related companies with MarketBeat.com's FREE daily email newsletter.